We have hypothesized a critical role for the inflammatory IKKbeta/NF-kappaB pathway in the pathogenesis of obesity- and diet-induced insulin resistance. We now know that the pathway is activated in fat and liver by obesity and high fat diet, that activation of NF-kappaB in fat and/or liver causes insulin resistance, that insulin resistance is transmissible by transplanting affected tissue (fat), and perhaps most importantly, that inhibition of IKKbeta and NF-kappaB, either genetically or pharmacologically, reverses insulin resistance in animals and humans. Elevations in inflammatory markers that are seen in patients are readily reproduced in rodent models of dietary and genetically induced insulin resistance. These are reversed in both rodents and humans in parallel with improvements in insulin resistance, and dramatic reductions in triglyceride, free fatty acid and glucose levels. To continue developing and testing these hypotheses, we now propose a comprehensive plan to identify primary sites of action and tissue-specific effects of genetic up- and down-regulation of NF-kappaB signaling and mechanisms for crosstalk and synergy between tissues. We are activating and inhibiting NF-kappaB selectively in fat, liver, muscle, beta cells and macrophages. Individually, each mouse line will be used to assess the effects on insulin sensitivity and other metabolic parameters. For example, activation of NF-kappaB in fat or liver causes systemic insulin resistance, whereas activation in muscle or beta cells does not. Preliminary results show that selective inhibition of NF-kappaB in fat or liver does the opposite, it prevents insulin resistance from developing even in high fat feeding or ob/ob mice. Additional experiments plan to look at the additive or ameliorative effects of simultaneous activation/inhibition in two tissues. These studies aim to identify a root cause of obesity- and diet-induced insulin resistance and the tissue-specific effects of inhibiting this pathway, and to determine mechanisms of crosstalk and synergy between tissues involved in the development of this very common disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK045943-08
Application #
6872633
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Blondel, Olivier
Project Start
1996-08-01
Project End
2009-12-31
Budget Start
2005-01-03
Budget End
2005-12-31
Support Year
8
Fiscal Year
2005
Total Cost
$390,100
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Goldfine, Allison B; Shoelson, Steven E (2017) Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest 127:83-93
Okazaki, Tatsuma; Liang, Feng; Li, Tong et al. (2014) Muscle-specific inhibition of the classical nuclear factor-?B pathway is protective against diaphragmatic weakness in murine endotoxemia. Crit Care Med 42:e501-9
Lee, Jongsoon; Miyazaki, Masaya; Romeo, Giulio R et al. (2014) Insulin receptor activation with transmembrane domain ligands. J Biol Chem 289:19769-77
Romeo, Giulio R; Pae, Munkyong; Eberlé, Delphine et al. (2013) Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes 62:3718-26
Kim, Myung-Sunny; Yamamoto, Yasuhiko; Kim, Kyungjin et al. (2013) Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. PLoS One 8:e82847
King, Aileen J F; Guo, Yongjing; Cai, Dongsheng et al. (2013) Sustained NF-?B activation and inhibition in ?-cells have minimal effects on function and islet transplant outcomes. PLoS One 8:e77452
Wong, Man C; van Diepen, Janna A; Hu, Lihui et al. (2012) Hepatocyte-specific IKK? expression aggravates atherosclerosis development in APOE*3-Leiden mice. Atherosclerosis 220:362-8
Schakman, O; Dehoux, M; Bouchuari, S et al. (2012) Role of IGF-I and the TNF?/NF-?B pathway in the induction of muscle atrogenes by acute inflammation. Am J Physiol Endocrinol Metab 303:E729-39
Langen, Ramon C J; Haegens, Astrid; Vernooy, Juanita H J et al. (2012) NF-?B activation is required for the transition of pulmonary inflammation to muscle atrophy. Am J Respir Cell Mol Biol 47:288-97
van Diepen, Janna A; Vroegrijk, Irene O C M; Berbée, Jimmy F P et al. (2011) Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 301:E1099-107

Showing the most recent 10 out of 29 publications